0001562180-21-005209.txt : 20210806
0001562180-21-005209.hdr.sgml : 20210806
20210806131309
ACCESSION NUMBER: 0001562180-21-005209
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210805
FILED AS OF DATE: 20210806
DATE AS OF CHANGE: 20210806
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoffman William
CENTRAL INDEX KEY: 0001304099
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 211152159
MAIL ADDRESS:
STREET 1: C/O INARI MEDICAL, INC.
STREET 2: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 9 PARKER, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-08-05
false
0001531048
Inari Medical, Inc.
NARI
0001304099
Hoffman William
C/O INARI MEDICAL, INC.
9 PARKER, SUITE 100
IRVINE
CA
92618
true
true
false
false
President and CEO
Common Stock
2021-08-05
4
S
false
2700.00
92.5785
D
758131.00
D
Common Stock
2021-08-05
4
S
false
17253.00
93.0846
D
740878.00
D
Common Stock
2021-08-05
4
S
false
10047.00
93.9607
D
730831.00
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020.
This transaction was executed in multiple trades at prices ranging from $91.76 to $92.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes 235 shares acquired on July 30, 2021 under the Employee Stock Purchase Plan since the reporting person's last Form 4 filing.
This transaction was executed in multiple trades at prices ranging from $92.77 to $93.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $93.77 to $94.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Angela Ahmad, attorney-in-fact for William Hoffman
2021-08-06